Valentina Prevolnik Rupel: No One Should Be Left Behind

Valentina Prevolnik Rupel

Thomas L. Harrison Joins the Board of Directors of P53 Inc.

Thomas L. Harrison

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

COSA-IPOS 2025 Kicks Off with Over 1,200 Attendees

COSA-IPOS 2025

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Zacharoula Sidiropoulou: What Really Works in Breast Cancer Screening Across Europe?

Zacharoula Sidiropoulou

Hesham ElGhazaly: Honored and Excited to be Announced as a Member of the ABC Global Alliance Board of Directors

Hesham ElGhazaly

Prince William Opens Up About Talking to His Children About Kate Middleton’s Cancer

Prince William Opens Up About Talking to His Children About Kate Middleton’s Cancer

OncoCalendar

« All Events

  • This event has passed.

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

Dec 16, 2024 • 7:00 PM - 9:00 PM
SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC will be held on December 16th, 2024.

This exclusive course will offer the latest updates on lung cancer treatment in Southeast Asia, with a special focus on immunotherapy. In Series II, renowned thoracic oncology experts from the region will delve into the role of immunotherapy in revolutionizing lung cancer care. Discussions will cover crucial topics such as the integration of biomarkers for immunotherapy, the best management strategies for advanced disease, and addressing challenges like pneumonitis. Participants will have the opportunity to explore how immunotherapy is set to transform the landscape of lung cancer treatment in Southeast Asia, bringing hope for improved patient outcomes.

See the Speakers and Southeast Asia Team Below:

SE Asia Course II: Immunotherapy in Lung Cancer By IASLC

Details

Organizer